ClinicalTrials.gov
ClinicalTrials.gov Menu

PASCAL Trabeculoplasty

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00804323
Recruitment Status : Unknown
Verified December 2008 by Asociación para Evitar la Ceguera en México.
Recruitment status was:  Recruiting
First Posted : December 8, 2008
Last Update Posted : December 9, 2008
Sponsor:
Information provided by:
Asociación para Evitar la Ceguera en México

Brief Summary:
Argon laser trabeculoplasty (ALT) with 100 ms pulses is an effective therapy for lowering intraocular pressure (IOP). Similar reductions in IOP have been achieved using ns (SLT) and microsecond (MLT) pulses, which produce less thermal damage to trabecular meshwork (TM). Lack of clinically visible changes may make the accurate alignment of subsequent pulses difficult. We describe a novel technique - Patterned Laser Trabeculoplasty (PLT) using the PASCAL Photocoagulator system, and its preliminary evaluation in patients with open angle glaucoma.

Condition or disease Intervention/treatment Phase
Open-Angle Glaucoma Procedure: Patter Scan Laser System (OptiMedica, Santa Clara, CA, USA) Phase 4

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 24 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Semi-Automated Patterned Laser Trabeculoplasty
Study Start Date : December 2007
Estimated Primary Completion Date : December 2008
Estimated Study Completion Date : December 2009

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Glaucoma

Arm Intervention/treatment
Experimental: Group 1
Patients with open-angle glaucoma
Procedure: Patter Scan Laser System (OptiMedica, Santa Clara, CA, USA)
Pattern Scan Laser trabeculoplasty




Primary Outcome Measures :
  1. Intraocular Pressure [ Time Frame: During follow-up ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 90 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • 18-year-old patients
  • Uncontrolled Open angle (Shaffer IV)
  • No previous surgical trabeculoplasty or glaucoma surgery

Exclusion Criteria:

  • Patients not willing to participate
  • Angle-closure glaucoma
  • No clear optical media

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00804323


Contacts
Contact: Felix Gil Carrasco, MD 525510841400 ext 1163 glaucoma_apec@hotmail.com

Locations
Mexico
Asociación para Evitar la Ceguera en México Recruiting
Mexico, DF, Mexico, 04030
Contact: Felix Gil Carrasco, MD    525510841400 ext 1163    glaucoma_apec@hotmail.com   
Principal Investigator: Mauricio Turati Acosta, MD         
Sub-Investigator: Adolfo Morales Gonzalez, MD         
Sponsors and Collaborators
Asociación para Evitar la Ceguera en México
Investigators
Principal Investigator: Felix Gil Carrasco, MD APEC

Responsible Party: Asociación para Evitar la Ceguera en Mexico, APEC
ClinicalTrials.gov Identifier: NCT00804323     History of Changes
Other Study ID Numbers: APEC-041
First Posted: December 8, 2008    Key Record Dates
Last Update Posted: December 9, 2008
Last Verified: December 2008

Additional relevant MeSH terms:
Glaucoma, Open-Angle
Glaucoma
Ocular Hypertension
Eye Diseases